相关实验视频

Updated: Jun 25, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

通过高通量查平台和理性设计开发向蛋白质药物载体

Xiaodan Li^1,2,3,4, Yanming Zuo^1,2,3,4, Xurong Lin^1,5

¹Department of Neurobiology and Department of Rehabilitation Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, 310003, P. R. China.

Advanced healthcare materials

|May 28, 2024

概括

开发有效的蛋白质输送系统对于先进的疗法至关重要. 一个新的高通量选平台,ProMatch,有效地识别了适合向蛋白质输送的聚合物,加速了创新治疗的开发.

科学领域:

生物材料科学生物材料科学
药物运输药物运输药物运输
纳米技术纳米技术

背景情况:

蛋白质疗法具有高特异性和低毒性,但由于蛋白质的不稳定性和复杂性质,它面临着交付挑战.
选择适合的聚合物来提供蛋白质是复杂的,因为蛋白质和聚合物的复杂性质.

研究的目的:

开发一个高通量选平台 (ProMatch),以有效收集蛋白质-聚合物相互作用的数据.
为了简化针对性蛋白质输送系统的聚合物选择.
为了证明平台在开发特定的治疗交付系统中的实用性.

主要方法:

开发了一个基于光的高通量选平台 (ProMatch),以评估蛋白质-聚合物相互作用.
在体内和体外实验是根据查结果进行合理设计的.
商用聚合物被选为向蛋白质输送应用.

主要成果:

ProMatch成功地加速了对组织特异性蛋白质输送有前途的聚合物候选物的识别.
一个基于聚乙烯比古安化物 (PHMB) 的系统被开发用于将蛋白质输送到白色脂肪组织,用于治疗肥胖症.
基于分支聚乙烯胺 (bPEI) 的系统被创建用于神经元特异性蛋白质的输送,以促进视神经的再生.

结论:

ProMatch平台显著加速了用于蛋白质输送的合适聚合物的发现.
这种方法为开发具有向交付能力的基于蛋白质的新疗法提供了坚实的基础.
开发的系统证明了ProMatch在为具有挑战性的医疗条件创造创新解决方案方面的潜力.

关键词:

在 ProMatch 里面,我们可以找到 ProMatch.肥胖肥胖肥胖肥胖肥胖肥胖肥胖肥胖视神经的再生和再生.聚合物是一种聚合物.蛋白质输送系统蛋白质输送系统这是白色脂肪组织.

更多相关视频

Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes

Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes

Published on: September 29, 2023

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...